🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study investigates the effect of acute smoking and time of day on blood...
Status
Recruiting
Location
University of Rostock
Start Date
2026-02-07
Trial ID
NCT07625111
Treatments Being Tested
This study is to evaluate the efficacy and tolerability of autologous adipo...
Status
Completed
Location
Aliaa Ismail
Start Date
2019-01-01
Trial ID
NCT03928444
This prospective observational study aims to evaluate whether immune profil...
Status
Not Yet Recruiting
Location
SMG-SNU Boramae Medical Center
Start Date
2026-01
Trial ID
NCT07331701
RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Status
Completed
Location
HealthOne Presbyterian St. Lukes Medical Center
Start Date
2006-01
Trial ID
NCT00322101
Treatments Being Tested
Myeloproliferative neoplasms (MPN) are hematological malignancies associate...
Status
Completed
Location
CHU de Bordeaux, Hématologie clinique et thérapie cellulaire
Start Date
2022-10-05
Trial ID
NCT05419648
Treatments Being Tested
This study will examine the safety and effectiveness of Alemtuzumab (Campat...
Status
Completed
Location
National Institutes of Health, National Cancer Institute
Start Date
2003-05
Trial ID
NCT00061048
Treatments Being Tested
RATIONALE: Pentostatin may stop the growth of cancer cells by blocking some...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2005-07
Trial ID
NCT00546377
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal hematol...
Status
Unknown
Location
London Health Sciences Centre
Start Date
2018-11-01
Trial ID
NCT03329365
RATIONALE: Alemtuzumab and glucocorticoids, such as prednisone or methylpre...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2006-07
Trial ID
NCT00410657
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic malignancy...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-13
Trial ID
NCT07113730
Treatments Being Tested